This page has moved. Click here to view.
Medical Library. Full Text Journals Medical Books Online. Physicians Drug Reference
I *Iatrogenic disorders -- Immunodeficiencies -- Immunofluorescent stains -- Impetigo Impingement syndrome -- Infectious diseases Infectious mononucleosis -- Influenza C virus Influenza vaccine -- Intercostal muscle cramps, pain of Interferon(s) -- Intestinal cestodes (tapeworms) Intestinal disease -- Intracerebral hemorrhage Intracerebral leukocytostasis -- Iron Iron chelation therapy, for thalassemias -- Isosporiasis (Isospora belli) -- Isotretinoin, for acne -- Ixodes
Iatrogenic disorders [ch1 ¶34]
IBS
[see: Irritable bowel syndrome (IBS)]
Ibuprofen
dosage [ch12 Table1]
for fever [ch17 ¶41]
poisoning/overdosage [ch391 ¶163]
Ichthyosis, in HIV disease [ch308 ¶255]
Icterus [ch45 ¶1]
[see also: Jaundice]
in pancreatitis [ch304 ¶50]
Idarubicin, for cancer [ch86 ¶69]
Ideational apraxia [ch25 ¶23]
Ideomotor apraxia [ch25 ¶22]
Idioventricular rhythm, accelerated (slow VT) [ch231 ¶76]
and myocardial infarction [ch243 ¶97]
Idoxuridine (IUdR) [ch183 ¶34]
for HSV [ch183 ¶34] [ch184 ¶39]
Ifosfamide
for cancer [ch86 ¶76]
cystitis from [ch104 ¶74]
nephrotoxicity [ch270 ¶12]
for non-Hodgkin's lymphoma [ch113 ¶57]
for testicular tumors [ch98 ¶25]
for urothelial tract malignancies [ch96 Table3]
IgH gene [ch84 Table4]
IkB molecule [ch83 ¶26]
Ileal-rectal anastomosis, for ulcerative colitis [ch286 ¶76]
Ileal resection
cobalamin deficiency and [ch108 ¶36]
and malabsorption [ch285 ¶61]
Ileitis, terminal, Yersinia [ch164 ¶37] [ch164 ¶49]
Ileoanal anastomosis, for ulcerative colitis [ch286 ¶76]
Ileostomy
continent, for ulcerative colitis [ch286 ¶76]
for Crohn's disease [ch286 ¶81]
Ileum, distal, diseases of, diarrhea from [ch42 ¶36]
Ileum
adynamic [ch289 ¶1] [ch289 ¶2] [ch289 ¶7]
treatment [ch289 ¶15]
drug-induced [ch69 Table1]
dynamic (spastic) [ch289 ¶1]
in sepsis [ch124 ¶20]
Iliopsoas bursitis [ch326 ¶72]
Imaging techniques [ch1 ¶24]
[see also: individual modalities]
Imbalance [ch21 ¶61-¶90]
algorithm for interpretation [ch21 Figure9]
defined [ch21 ¶61]
differential diagnosis [ch21 ¶72-¶78]
examination for [ch21 ¶71]
pathogenesis [ch21 Figure6] [ch21 Figure7] [ch21 Figure8] [ch21 ¶62-¶69]
with sensory ataxia [ch21 ¶76]
with vestibular dysfunction [ch21 ¶75]
Imidazoles
for amebiasis [ch215 Table1]
for dermatophytosis [ch55 ¶39]
systemic [ch202 ¶12-¶20]
topical [ch202 ¶7]
Iminoglycinuria [ch350 ¶19] [ch350 Table1]
Iminopeptiduria [ch349 Table1]
Imipenem [ch140 ¶75]
dosage
for pneumonia [ch255 Table8]
in renal failure [ch68 Table3]
for nontuberculous mycobacteria [ch170 ¶61]
pharmacokinetics [ch140 Table3]
for pneumococcal infections [ch141 ¶29]
resistance [ch140 ¶75]
Imipramine
for pain, dosage [ch12 Table1]
for panic disorders [ch385 ¶11]
poisoning/overdosage [ch391 ¶189]
Immediate type hypersensitivity [ch310]
[see also: Hypersensitivity, immediate-type]
Immobilization
in the elderly [ch9 ¶61-¶67]
consequences of [ch9 ¶63]
treatment [ch9rx2]
and hypercalcemia [ch354 ¶90-¶91]
and incontinence [ch9 ¶41]
and venous thrombosis [ch248 ¶61]
Immune-complex formation [ch305 ¶75]
Immune-mediated injuries [sc2ch310]
ankylosing spondylitis, reactive arthritis, and undifferentiated spondyloarthropathy [ch317]
Behçet's syndrome [ch318]
dermatomyositis/polymyositis [ch315]
immediate type hypersensitivity [ch310]
nephropathies [ch276 ¶29-¶34]
protein-energy malnutrition and [ch74 ¶15]
rheumatoid arthritis [ch313]
sarcoidosis [ch320]
Sjögren's syndrome [ch316]
skin diseases [ch311]
systemic lupus erythematosus [ch312]
systemic sclerosis [ch314]
from transfusions [ch115 ¶39-¶48]
vasculitis syndromes [ch319]
in women [ch6 ¶24]
Immune system
age-related changes in [ch9 Table1]
B cells [ch305 Figure7] [ch305 Figure8] [ch305 ¶28-¶35] [ch305 Table5]
[see also: B cell(s)]
CD classification of human lymphocyte differentiation antigens [ch305 ¶3] [ch305 Table2]
cellular interactions in regulation of [ch305 Figure10] [ch305 Figure11] [ch305 ¶54-¶61]
clinical functional evaluation [ch305 ¶86] [ch305 Table10]
complement system [ch305 Figure12] [ch305 ¶62-¶66] [ch305 Table8]
cytokines [ch305 ¶4-¶6]
[see also: Cytokines]
dendritic/Langerhans cells [ch305 ¶41]
follicular dendritic cells [ch305 ¶42]
HIV disease and [ch308 ¶98-¶108] [ch308 Table9]
immunoglobulins [ch305 Figure9] [ch305 ¶47-¶53] [ch305 Table7]
[see also: Immunoglobulin(s)]
infections and [ch120 ¶19-¶23]
interventional immunotherapy [ch305 ¶87-¶88]
large granular lymphocytes (NK cells) [ch305 ¶36-¶38]
mechanisms of damage [ch305 ¶67-¶85]
anaphylaxis [ch305 ¶76]
autoimmune disease [ch305 ¶80-¶83]
cellular and molecular control of apoptosis [ch305 Figure14] [ch305 ¶84-¶85]
cytotoxic reaction of antibody [ch305 ¶77]
delayed-type hypersensitivity [ch305 ¶78-¶79]
immune-complex formation [ch305 ¶75]
molecular basis of lymphocyte-endothelial cell interactions [ch305 Figure13] [ch305 ¶69-¶74] [ch305 Table9]
monocytes-macrophages [ch305 ¶39-¶40]
neutrophils, eosinophils, and basophils [ch305 ¶43-¶46] [ch305 Table6]
overview of [ch305]
disorders [sc1ch305] [ch305 Table1]
[see also: individual disorders]
parasitic infections and [ch212 ¶8]
phenotypes and function of cells [ch305 Figure2] [ch305 ¶7-¶46] [ch305 Table3]
[see also: individual cells]
T cells [ch305 Figure3] [ch305 Figure4] [ch305 Figure5] [ch305 Figure6] [ch305 ¶10-¶27] [ch305 Table4]
[see also: T cell(s)]
Immunization [ch122] [ch10 ¶20] [ch10 Table2]
[see also: Vaccines and individual vaccines]
access to [ch122 ¶58-¶62] [ch122 Table11] [ch122 Table12]
active [ch122 ¶4]
approaches [ch122 ¶6]
adjuvant potentiation [ch122 ¶11]
for adolescents [ch8 ¶45]
age and [ch122 ¶10]
contraindications and precautions [ch122 Table6]
cost-effectiveness of [ch11 ¶31]
definitions [ch122 ¶4] [ch122 Table2]
for the elderly [ch9 ¶84]
financing [ch122 ¶61-¶62]
herd immunity [ch122 ¶18]
hypersensitivity reactions [ch122 ¶15]
impact of [ch122 ¶3]
for infants and children [ch122 Figure2] [ch122 ¶41] [ch122 Table4]
international considerations [ch122 ¶72-¶74]
mucosal immunity [ch122 ¶16]
National Vaccine Injury Compensation program [ch122 ¶65]
passive [ch122 ¶4]
[see also: Immunoglobulin(s)]
approaches [ch122 ¶7-¶8]
postexposure [ch122 ¶52] [ch122 Table9]
principles [ch122 ¶5]
reemergence of controlled disease [ch122 ¶70]
research [ch122 ¶68-¶71]
response to [ch122 ¶12-¶17]
measurement of [ch122 ¶17]
primary [ch122 ¶13]
secondary [ch122 ¶14]
role of industry [ch122 ¶64]
route of administration [ch122 ¶9]
sources of information on [ch122bl1]
standards for practice [ch122 ¶63] [ch122 Table14]
target populations [ch122 ¶19-¶22]
timing [ch122 ¶19-¶22]
for viruses [ch182 ¶50]
Immunoblotting [ch65 ¶44] [ch65 Table2]
[see also: Western blot]
Immunocompromised host
AIDS
[see: Human immunodeficiency virus (HIV) disease]
aspergillosis in [ch208 ¶2] [ch208 ¶7]
brain abscess in [ch377 ¶46]
bronchiectasis in [ch256 ¶6-¶7]
from cancer
[see: Cancer]
from cancer chemotherapy
[see: Chemotherapy]
chest infiltrates in [ch87 Table5]
cytomegalovirus in [ch187 ¶18-¶25] [ch187 Table1]
Epstein-Barr virus in [ch186 ¶17-¶18]
esophagitis [ch283 ¶53]
fungal sinusitis in [ch30 ¶20]
herpes simplex virus in [ch184 ¶9]
orofacial infections [ch184 ¶18]
treatment [ch183 Table1] [ch184 Table1]
human papillomavirus in [ch190 ¶9]
listeriosis in [ch145 ¶9]
measles in [ch196 ¶16]
meningitis in [ch378 ¶22]
mycobacterial infections, nontuberculous, in [ch173 ¶11-¶15]
neutropenics
[see: Neutropenia]
nodular eruptions in [ch18 ¶19]
osteomyelitis in [ch132 ¶14]
parvovirus B19 in [ch189 ¶4] [ch189 ¶10]
pneumonia in [ch255 ¶19]
prophylactic antibiotics for [ch136 Table4] [ch136 Table5]
Pseudomonas aeruginosa in [ch157 ¶17-¶19]
from transplantation
[see: Transplantation and specific organ transplants]
vaccines for [ch122 ¶50-¶51] [ch122 Table8]
and travel [ch136 ¶52]
varicella-zoster virus in [ch185 ¶19] [ch185 ¶25]
treatment [ch183 Table1] [ch185 ¶29]
Immunodeficiencies [ch305 Table1]
[see also: individual disorders]
acquired [ch305 Table1]
[see also: Human immunodeficiency virus (HIV) disease]
antibody [ch305 Table1]
bone marrow transplantation for [ch116 ¶36]
cellular, evaluation [ch307 ¶25-¶27]
combined [ch305 Table1]
humoral, evaluation [ch307 ¶22-¶24]
immunoglobulins [ch307 ¶48-¶64]
[see also: Immunoglobulin deficiency syndromes]
metabolic abnormalities and [ch307 ¶73]
occupational/environmental exposures and [ch5 ¶20]
primary [ch307] [ch305 Table1]
[see also: specific immunodeficiencies]
classification [ch307 ¶28-¶78] [ch307 Table2]
clinical disease features [ch307 ¶2-¶9]
evaluation [ch307 ¶21-¶27]
T and B cell differentiation and [ch307 ¶10-¶20]
secondary, classification [ch307 ¶29]
severe combined (SCID) [ch307 ¶32-¶37]
bone marrow transplantation for [ch116 ¶36]
syndromes associated with [ch305 Table1]
T cell [ch307 ¶38-¶47]
[see also: T cell immunodeficiency and specific diseases]
with thymoma [ch307 ¶68]
treatment [ch307rx2]
I *Iatrogenic disorders -- Immunodeficiencies -- Immunofluorescent stains -- Impetigo Impingement syndrome -- Infectious diseases Infectious mononucleosis -- Influenza C virus Influenza vaccine -- Intercostal muscle cramps, pain of Interferon(s) -- Intestinal cestodes (tapeworms) Intestinal disease -- Intracerebral hemorrhage Intracerebral leukocytostasis -- Iron Iron chelation therapy, for thalassemias -- Isosporiasis (Isospora belli) -- Isotretinoin, for acne -- Ixodes
Ichthyosiform Dermatoses
Ichthyosiform Erythroderma
Ichthyosiform Dermatoses
Ichthyosis (Acquired)
Ichthyosis (Lamellar)
Id Reaction (Autoeczematization)
Idiopathic Guttate Hypomelanosis
Idiopathic Thrombocytopenic Purpura
Ileitis
Ileocolitis
Ileus
Iminoglycinuria
Immune Complex Disease
Immunoglobulin A Deficiency
Immunoglobulin D Deficiency
Immunoglobulin M Deficiency
Immunoglobulin G Deficiency
Immunoproliferative Small Intestinal Disorder (Alpha Heavy Chain Disease)
Impetigo
Incontinentia Pigmenti
Infantile Digital Fibromatosis
Infantile Hemangioma
Inferior Vena Caval Thrombosis
Infertile Male Syndrome
Infertility
Inflammatory Bowel Disease
Influenza
Infrainguinal Occlusive Disease
Insect Bites
Insecticide Poisoning
Insomnia
Insulin Resistance
Insulinoma
Internal Jugular Vein Thrombosis
Intertrigo
Intestinal Flukes
Intestinal Perforation
Intestinal Leiomyosarcoma
Intestinal Leiomyoma
Intestinal Polypoid Adenomas
Intestinal Radiation Injury
Intestinal Fistulas
Intestinal Motility Disorders
Intestinal Pseudoobstruction
Intestinal Lymphangiectasia
Intraabdominal Sepsis
Iodine Deficiency
Iron Deficiency Anemia
Iron Poisoning
Irritable Bowel Syndrome
Isoniazid Hepatotoxicity
Isosporiasis
Isovaleric Acidemia
Itai-Itai Disease